FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to derivatives of quinoxaline of the formula (I) where A - nitrogen or CH; R1,R2 - alkyl, halide or ; R4 - H, cycloalkyl or alkyl possibly substituted with hydroxy-, alkoxy-group, phenyl, pyridinyl, morpholinyl, benzimidazolyl, pyrazolyl, ozoxazol or phthalimidyl, C2-6-alkenyl, C2-6-alkynyl, C2-6-alkanoyl, carboxy-group, aminoalkoxycarbonyl, alkylamino-, dialkylamino- -group, NHSO2CF3, CONR5R6, O(CH2)nNR5R6, NHCO-NR5R6;; R5, R6 - H, alkyl or in common with nitrogen atom form pyrrolidino- or morpholino-group; n = 2, 3 or 4, and their pharmaceutically acceptable salts that show anxiolytic, anticonvulsant, analgetic or neuroprotective activity. EFFECT: improved method of synthesis, valuable pharmacological activity. 15 cl, 3 tbl, 30 ex
Authors
Dates
1999-08-27—Published
1995-09-08—Filed